Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Early Hum Dev. 2013 Jan 9;89(6):411–418. doi: 10.1016/j.earlhumdev.2012.12.006

Table 2B. CD34+ cell subsets in MNC fraction of preterm infants for the first 3 weeks of life.

MNC Day N Median Q1 Q3 Min Max
CD34+ 1 27 3642.26 1492.12 4797.88 428.50 16744.01
7 22 3516.27 1756.70 5136.00 1068.00 9788.02
14 15 4000.00 1527.74 5546.00 842.00 9308.00
21 15 3453.69 2644.00 4818.00 1412.00 7622.58
P 0.7632
CD34+CD45− 1 27 130.14 74.41 225.50 27.36 1547.00
7 22 219.70 155.42 371.30 32.97 691.00
14 15 303.00 181.00 638.66 79.20 893.48
21 14 306.29 186.00 396.00 93.00 1311.99
P 0.0882
CD34+VEGFR2 1 27 76.06 50.00 130.00 2.70 436.00
7 21 170.94 38.44 284.13 2.35 1536.82
14 15 126.84 42.70 213.34 29.31 1102.06
21 13 133.81 63.74 239.60 20.56 585.60
P 0.0715
CD34+CD45−VEGFR2+
(EPC)
1 27 2.22 0.20 6.50 0.00 62.10
7 22 5.75 2.33 9.14 0.00 106.60
14 15 2.70 0.80 11.20 0.00 24.10
21 14 3.25 0.00 9.78 0.00 19.60
P 0.307

Data presented as number of events per million MNC gated